Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Heene

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Anti-Cancer Drugs|August 1, 1997
The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in ratsG Stehle, H Sinn, A Wunder, et al.
International Journal of Cancer|June 17, 1998
Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinomaA Wunder, G Stehle, H H Schrenk, et al.
Annals of the New York Academy of Sciences|July 20, 2001
Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activityC E Dempfle, S Argiriou, S Alesci, et al.
Zeitschrift Fur Kardiologie|July 1, 1986
[Dose-effect relation of N-prajmalium bitartrate with control of plasma levels]R Elfner, W Kollmeier, A Lentz, et al.
Klinische Wochenschrift|September 16, 1991
Differences in the risk factor patterns for coronary heart disease in China, Japan, and GermanyG Stehle, S Hinohara, P Cremer, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Pharmacokinetic properties of LMW-heparin-tyramine fractions with high or low affinity to antithrombin III in the ratG Stehle, A Wunder, H Sinn, et al.
Deutsche Medizinische Wochenschrift (1946)|April 23, 1971
[Clinical features of disseminated intravascular coagulation]H G Lasch, K Huth, D L Heene, et al.
The Journal of Clinical Investigation|November 1, 1992
Hepatic uptake of a modified low molecular weight heparin in ratsG Stehle, E A Friedrich, H Sinn, et al.
Critical Reviews in Oncology/Hematology|July 1, 1997
Plasma protein (albumin) catabolism by the tumor itself--implications for tumor metabolism and the genesis of cachexiaG Stehle, H Sinn, A Wunder, et al.
The Journal of Surgical Research|February 1, 1995
Complexes of a modified low-molecular-weight heparin with protamine are predominantly cleared by a macrophage scavenger receptor-mediated process in ratsG Stehle, A Wunder, H Sinn, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Anti-Cancer Drugs|August 1, 1997
The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in ratsG Stehle, H Sinn, A Wunder, et al.
International Journal of Cancer|June 17, 1998
Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinomaA Wunder, G Stehle, H H Schrenk, et al.
Annals of the New York Academy of Sciences|July 20, 2001
Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activityC E Dempfle, S Argiriou, S Alesci, et al.
Zeitschrift Fur Kardiologie|July 1, 1986
[Dose-effect relation of N-prajmalium bitartrate with control of plasma levels]R Elfner, W Kollmeier, A Lentz, et al.
Klinische Wochenschrift|September 16, 1991
Differences in the risk factor patterns for coronary heart disease in China, Japan, and GermanyG Stehle, S Hinohara, P Cremer, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Pharmacokinetic properties of LMW-heparin-tyramine fractions with high or low affinity to antithrombin III in the ratG Stehle, A Wunder, H Sinn, et al.
Deutsche Medizinische Wochenschrift (1946)|April 23, 1971
[Clinical features of disseminated intravascular coagulation]H G Lasch, K Huth, D L Heene, et al.
The Journal of Clinical Investigation|November 1, 1992
Hepatic uptake of a modified low molecular weight heparin in ratsG Stehle, E A Friedrich, H Sinn, et al.
Critical Reviews in Oncology/Hematology|July 1, 1997
Plasma protein (albumin) catabolism by the tumor itself--implications for tumor metabolism and the genesis of cachexiaG Stehle, H Sinn, A Wunder, et al.
The Journal of Surgical Research|February 1, 1995
Complexes of a modified low-molecular-weight heparin with protamine are predominantly cleared by a macrophage scavenger receptor-mediated process in ratsG Stehle, A Wunder, H Sinn, et al.
Pageof 15